期刊文献+

AGEs调节NF-κB通路对软骨细胞炎症因子IL-1β的影响 被引量:3

Effects of AGEs on IL-1βExpression in Chondrocytes via IL-κB Pathway
下载PDF
导出
摘要 目的观察AGEs调节NF-κB通路对软骨细胞炎症因子IL-1β表达的影响。方法将软骨细胞传代培养,取对数生长的软骨细胞接种于96孔板,分为对照组、低剂量AGEs(20μg/L)组、高剂量AGEs(40μg/L)组、NF-κB通路抑制剂PDTC(5μg/L)组和AGEs(40μg/L)+PDTC(5μg/L)组,共培养24 h后ELISA检测各组上清液中IL-1β的含量,Real-time PCR检测各组IL-1β和P65基因表达,Western-blot检测IL-1β和P65蛋白表达。结果对照组软骨细胞上清液中IL-1β的浓度明显高于低剂量AGEs组和高剂量AGEs组,差异有统计学意义(P<0.05);PDTC组和AGEs+PDTC组软骨细胞上清液中IL-1β含量与对照组比较明显下降(P<0.05)。对照组软骨细胞中IL-1β和P65 mRNA相对表达量高于低剂量组和高剂量组(P<0.05),低于PDTC组(P<0.05)。PDTC组IL-1β和P65 mRNA相对表达量低于AGEs+PDTC组(P<0.05)。对照组软骨细胞中IL-1β和P65蛋白相对表达量低于低剂量组和高剂量组(P<0.05),但高于PDTC组(P<0.05)。PDTC组软骨细胞中IL-1β和P65蛋白相对表达量较AGEs+PDTC组减少(P<0.05)。结论AGEs上调软骨细胞IL-1β的表达,NF-κB通路可能是参与骨关节炎发生发展的重要通路之一。 Objective To study effects of AGEs modulating NF-κB pathway on inflammatory factor IL-1βin chondrocytes.Methods Chondrocytes were subcultured.Chondrocytes in logarithmic growth phase were seeded into 96-well plates and were divided into control group,low-dose AGEs(20μg/L)group,high-dose AGEs(40μg/L)group,NF-κB pathway inhibitor PDTC(5μg/L)group and high-dose AGEs(40μg/L)+inhibitor PDTC(5μg/L)group.After 24 hours of co-cultivation,IL-1βin supernatant was tested by ELISA.Real-time PCR was carried out to detect IL-1βand P65 gene.Moreover,western blot was conducted to exam IL-1βand P65 protein.Results IL-1βin chondrocyte supernatant in control group was prominently higher than that in low-dose AGEs group and high-dose AGEs group with statistically significant difference(P<0.05).IL-1βin chondrocyte supernatant of PDTC group and high-dose AGEs+PDTC group was markedly lower than that of control group(P<0.05).Relative expressions of IL-1βand P65 mRNA in chondrocytes in control group were higher than that in low-dose AGEs group and high-dose AGEs group(P<0.05),and lower than PDTC group as well(P<0.05).Relative expressions of IL-1βand P65 mRNA in PDTC group were lower than that in AGEs+PDTC group(P<0.05).Relative expressions of IL-1βand P65 protein in chondrocytes in control group were lower than those in low-dose and high-dose AGEs group(P<0.05),but higher than those in PDTC group(P<0.05).Besides,relative expressions of IL-1βand P65 protein in chondrocytes in PDTC group were reduced in AGEs+PDTC group(P<0.05).Conclusion AGEs boost IL-1βecpression through NF-κB pathway that may be one of the important pathways involved in the occurrence and progression of osteoarthritis.
作者 吴剑 张柘 陈沼飞 刘艳西 秦星星 石振 Wu Jian;Zhang Zhe;Chen Zhaofei(The First Affiliated Hospital of Hubei University of Science and Technology&Xianning Central Hospital,Xianning,Hubei 437100;School of Medicine,Hubei University of Science and Technology,Xianning,Hubei 437100,China)
出处 《四川医学》 CAS 2021年第11期1077-1081,共5页 Sichuan Medical Journal
基金 湖北省卫计委资助项目(编号:WJ2019M094) 咸宁市中心医院重点支助项目(编号:XY2018Z53)。
关键词 AGES NF-ΚB通路 软骨细胞 IL-1Β AGEs NF-κB pathway chondrocytes IL-1β
  • 相关文献

参考文献2

二级参考文献19

  • 1[1]Neeper M, Schmidt AM, Brett J, et al.Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of protein. J Biol Chem, 1992, 267:14998~15004.
  • 2[2]Schmidt AM, Yan SD, Yan SF, et al.The biology of the receptor for advanced glycation end products and its ligands. Biochim Biophys Acta, 2000, 1498:99~111.
  • 3[3]Yeh CH, Sturgis L, Haidacher J, et al.Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion. Diabetes, 2001, 50: 1495~1504.
  • 4[4]Vlassara H, Bucala R, Striker L, et al.Pathogenic effects of advanced glycosylation:biochemical, biologic, and clinical implications for diabetes and aging. Lab Invest, 1994, 70: 138~151.
  • 5[5]Hou FF, Reddan DN, Seng WK, et al. Pathogenesis of β2-microglobulin amyloidosis: role of monocytes/macrophages. Semin Dial. 2001, 14: 135~139.
  • 6[6]Sun M, Muinehiro Y, Toshiyuki I, et al.Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat. Int J Exp Path, 1998, 79: 207~222.
  • 7[7]Hou FF, Jiang JP, Guo JQ, et al. Receptor for advanced glycation end products on human synovial fibroblasts: role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol, 2002, 13: 1296~1306.
  • 8[8]Higashi T, Sano H, Saishoji T, et al.The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes, 1997, 46: 463~472.
  • 9[9]Hou FF, Miyata T, Boyce J, et al. β2-Microglobulin modified with advanced glycation end products delays monocyte apoptosis. Kidney Int. 2001, 59: 990~1002.
  • 10Lohmander L S,Hoerrner L A,Lark MW,et al.Metalloproteinases,tissueinhibitor,and proteoglycan fragments inknee synovial fluid in human osteoarthritis[].Arthritis and Rheumatism.2005

共引文献34

同被引文献77

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部